Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15007 total
CHWY enters Tuesday's September 9 print with shorts rebuilding, analysts divided, and the options market leaning in the opposite direction — a three-way split that makes the setup harder to read than the numbers alone…
ROKU short sellers are pressing harder into a stock where the analyst community has spent the past month stepping back, creating a rare alignment of bearish signals on a name that is still up 5.6% over the past…
SG Micro Corp enters September under modest pressure, down 6.6% on the week to CNY 106.92, yet the Street's mean price target of CNY 132.44 implies roughly 24% upside — a gap that makes the valuation conversation the…
UBS Group AG heads into the final stretch of summer with a curious split: the stock is grinding higher, analyst targets are almost exactly met, and insiders are consistently cashing out. The insider selling is the…
FSLR is drifting lower with no catalyst to shake short sellers loose — down 1.4% on the week and 16% over the past month — while the October 27 earnings date draws closer and the covering impulse that defined…
Allison Transmission enters the final stretch of Q3 with a clean divergence at its core: the stock is up 7% over the past month and short sellers are backing away, yet the CEO sold nearly $3.6 million worth of shares…
Elisa Oyj enters the first week of September on the back foot, down 1.9% on the week to €35.46, while its ORTEX short score has quietly climbed to its highest point in at least two weeks — a subtle shift worth watching…
PEY, the Invesco High Yield Equity Dividend Achievers ETF, is closing out the week with a notable borrow-market whipsaw — availability collapsed to near its tightest level of the past year just two weeks ago, then…
Take-Two Interactive faces an uncomfortable juxtaposition: a stock down nearly 9% on the week, a once-in-a-decade franchise catalyst approaching in November, and a CEO who sold roughly $5.6 million worth of shares…
The Bitwise XRP ETF XRP enters the first week of September with a striking divergence: options traders are the most bullish they have been all year, even as the fund pulls back nearly 5% in a single session after a…
Inhibrx Biosciences has put in one of biotech's more dramatic single-month moves — up 45% to $121.17 — yet short sellers haven't flinched, and two company insiders remain on the SEC's activist register with Schedule…
AngloGold Ashanti enters September with a sharp near-term reversal sitting awkwardly on top of one of the strongest monthly gains in the gold sector. The stock closed at $109.07 on September 4, down 2.3% on the day and…
GRND heads into the September stretch with a curious split: the stock has shed 15% over the past month and slipped another 2.2% this week, yet short sellers are quietly covering and options traders are among the most…
NewAmsterdam Pharma heads into the autumn with a curious split: short interest has risen sharply over the past month while the options market has turned markedly less bearish — two signals pointing in opposite…
TOP Financial Group enters September with an unusual combination of forces at play — a fresh activist filing, a borrow market that tightened sharply through the week, and a stock that has given back 10% in seven days…
STX enters the first week of September riding a 6.3% single-day jump to $849.28, yet trading nearly 25% below a Street consensus target that clusters well above $1,100 — a gap that tells the more interesting story than…
SLN enters September with a striking split personality: the stock is up 31% over the past month and 9% on the week, yet short interest has climbed roughly 55% in the same 30-day window — a rare setup where momentum…
Bloom Energy enters the first week of September with its sharpest weekly gain in months, a sprawling lead over its closest competitors, and a short base that has been quietly unwinding — a combination that makes the…
KKR enters the first week of September with an interesting disconnect: the street is lifting price targets aggressively, yet the stock has slipped nearly 1% on the week to $107.73, sitting roughly 16% below the…
ACA heads into the back half of the year with a strong price run behind it and the first signs of a quieter, more measured options market emerging from an unusually defensive stretch. The most interesting tension this…
